We present the case of a 53-year-old woman with breast cancer who developed vertebral body metastases at the 7-10th thoracic vertebrae (Th7-10) and started radiotherapy in April 2011. Radiotherapy was administered in 15 fractions of 2.5 Gy each to the vertebral bodies. Total dose to the tumor was 37.5 Gy. She gradually developed severe paresthesia and numbness of the lower extremities, and sensory deficit below the Th7 level was revealed in July 2013. Laboratory tests, which included cerebrospinal fluid analysis, were unremarkable. Magnetic resonance imaging (MRI) of the spinal cord demonstrated an intramedullary enhanced lesion extending at the Th7-8 level on gadolinium-enhanced images (Fig. 1a) . T2-weighted images showed an oval hyperintense signal area and edema (Fig. 1b) (Fig. 1c) and delayed (Fig. 1d) slices. The avid lesion had fusiform morphology. Delayed 18 F-FDG PET-CT showed a 30.4 % increment of SUVmax (retention index was 30.4 %) that suggested malignancy; therefore we suspected ISCM. She received steroid pulse therapy for discrimination from DRM, but it was not effective and neurological findings were getting worse. Follow-up MRI showed expansion of the intramedullary lesion and new appearance of the vertebral body metastasis at Th3 on gadolinium-enhanced images in April 2014 (Fig. 1e) . On the basis of her clinical and radiological findings, ISCM was diagnosed.
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The results of such studies showed that most of the SUV values in malignant lesions were increased in the delayed scan and for most benign lesions these delayed values decreased [1] . In 18 F-FDG PET/CT images, ISCM showed pathological FDG uptake, but, on the other hand, DRM showed no pathological FDG uptake [2, 3] .
In conclusion, 18 F-FDG PET/CT has an important role to play in the diagnosis of ISCM and the differentiation from DRM. 
